Cell MedX Corp. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2014 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Cell MedX Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2014 to Q2 2024.
- Cell MedX Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending May 31, 2024 was $1.88M, a 0.81% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)